Search hospitals
>
Ohio
>
Cleveland
University Hospitals Cleveland Medical Center
Claim this profile
Cleveland, Ohio 44106
Global Leader in Lung Cancer
Global Leader in Cancer
Conducts research for Solid Tumors
Conducts research for Pancreatic Cancer
Conducts research for Heart Failure
927 reported clinical trials
125 medical researchers
Summary
University Hospitals Cleveland Medical Center is a medical facility located in Cleveland, Ohio. This center is recognized for care of Lung Cancer, Cancer, Solid Tumors, Pancreatic Cancer, Heart Failure and other specialties. University Hospitals Cleveland Medical Center is involved with conducting 927 clinical trials across 1,225 conditions. There are 125 research doctors associated with this hospital, such as Pedro M. Barata, Afshin Dowlati, MD, Amit Mahipal, MD, and Lauren Henke, MD.
Area of expertise
Lung Cancer
University Hospitals Cleveland Medical Center has run 68 trials for Lung Cancer. Some of their research focus areas include:
Cancer
University Hospitals Cleveland Medical Center has run 46 trials for Cancer. Some of their research focus areas include:
Top PIs
Pedro M. Barata
Tulane University Health Sciences Center
1 year of reported clinical research
Afshin Dowlati, MD
University Hospitals Cleveland Medical Center
1 year of reported clinical research
Amit Mahipal, MD
Mayo Clinic
4 years of reported clinical research
Lauren Henke, MD
Washington University School of Medicine
4 years of reported clinical research
Clinical Trials running at University Hospitals Cleveland Medical Center
Ovarian Cancer
Lung Cancer
Crohn's Disease
Multiple Myeloma
Prostate Cancer
Esophageal Cancer
Psoriasis
Postoperative Pain
Non-Small Cell Lung Cancer
Colorectal Cancer
Rina-S
for Ovarian Cancer
This phase 3 study will be conducted in different countries all over the world. The purpose of this study is to compare how well Rina-S works against platinum-resistant ovarian cancer compared to chemotherapy drugs that are already approved and used for platinum-resistant ovarian cancer. Treatment in this study could be Rina-S or it could be 1 of 4 indicated chemotherapy agents that are considered standard medical care. There is an equal (50:50) chance of getting Rina-S or an approved chemotherapy agent as treatment in this study. No one will know what treatment they are assigned to until the first dose. All participants will receive active drug; no one will be given placebo.
Recruiting
2 awards
Phase 3
4 criteria
Heated Chemotherapy + Niraparib
for Ovarian Cancer
Patients will be registered prior to, during or at the completion of neoadjuvant chemotherapy given per standard institutional guidelines +/- bevacizumab on Day 1 every 21 days for 3-4 cycles. Registered patients who progress during neoadjuvant chemotherapy will not be eligible for iCRS and will be removed from the study. Following completion of neoadjuvant chemotherapy, interval cytoreductive surgery (iCRS) will be performed in the usual fashion in both arms. Patients will be randomized at the time of iCRS (iCRS must achieve no gross residual disease or no disease \>1.0 cm in largest diameter) to receive HIPEC or no HIPEC. Patients randomized to HIPEC Arm will receive a single dose of cisplatin (100mg/m2 IP over 90 minutes at 42 C) as HIPEC. After postoperative recovery patients will receive standard post-operative platinum-based combination chemotherapy. Patients randomized to surgery only (No HIPEC Arm) will receive postoperative standard chemotherapy after recovery from surgery. Both groups will receive an additional 2-3 cycles of platinum-based combination chemotherapy per standard institutional guidelines +/- bevacizumab for a maximum total of 6 cycles of chemotherapy (neoadjuvant plus post-operative cycles) followed by niraparib individualized dosing +/- bevacizumab until progression or 36 months (if no evidence of disease).
Recruiting
2 awards
Phase 3
ZN-c3
for Serous Carcinoma
This is a multi-part Phase 2 study to evaluate the efficacy and safety of azenosertib (ZN-c3) in subjects with Platinum-Resistant, High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer. Part 2 of the study will be conducted in subjects whose tumors are Cyclin E1 positive as determined by central review using the Sponsor's investigational clinical trial assay.
Recruiting
1 award
Phase 2
1 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University Hospitals Cleveland Medical Center?
University Hospitals Cleveland Medical Center is a medical facility located in Cleveland, Ohio. This center is recognized for care of Lung Cancer, Cancer, Solid Tumors, Pancreatic Cancer, Heart Failure and other specialties. University Hospitals Cleveland Medical Center is involved with conducting 927 clinical trials across 1,225 conditions. There are 125 research doctors associated with this hospital, such as Pedro M. Barata, Afshin Dowlati, MD, Amit Mahipal, MD, and Lauren Henke, MD.
Where is University Hospitals Cleveland Medical Center located?
University Hospitals Cleveland Medical Center is located at 11100 Euclid Ave, Cleveland, Ohio. For real-time driving directions, consider using Waze to navigate to the main campus.
Who should I call to ask about financial aid or insurance network?
**University Hospitals Cleveland Medical Center Financial Assistance and Insurance Contact Information:** - **Financial Counselors:** For assistance with specialized service estimates, insurance eligibility, and financial assistance, call 1-866-771-7266 (Monday – Friday: 8 a.m. – 4:30 p.m.). - **Hospital Care Assurance Program (HCAP):** For information, contact 216-844-2447, 216-844-8299, or toll-free 1-800-859-5906. - **General Billing Inquiries:** Reach the UH Customer Service Department at 216-844-8299 (Monday – Friday: 8 a.m. – 5:30 p.m.).
What insurance does University Hospitals Cleveland Medical Center accept?
The University Hospitals Cleveland Medical Center accepts a variety of major insurance plans such as Aetna, Anthem, Cigna, Medical Mutual of Ohio, and United Healthcare. For a detailed list of accepted insurance plans, please consult our health insurance directory. Always verify with your insurance provider to confirm coverage details and financial responsibilities for your care.
What awards or recognition has University Hospitals Cleveland Medical Center received?
University Hospitals Cleveland Medical Center is ranked among the nation's Best Hospitals in seven adult specialties by U.S. News & World Report. It has been recognized as a Magnet organization for nursing excellence and received the Lantern Award for exceptional emergency department care. Additionally, it has been named one of the World's Most Ethical Companies by the Ethisphere Institute.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.